Observational study / 1999
Symptomatic gastroesophageal reflux was strongly associated with an increased risk of esophageal adenocarcinoma.
A nationwide population-based case-control study in Sweden evaluated the relationship between gastroesophageal reflux symptoms and esophageal or gastric cardia tumors. Compared with persons without recurrent reflux symptoms, those with recurrent symptoms had odds ratios of 7.7 (95% CI, 5.3 to 11.4) for esophageal adenocarcinoma and 2.0 (95% CI, 1.4 to 2.9) for adenocarcinoma of the cardia. For persons with long-standing and severe symptoms, odds ratios reached 43.5 (95% CI, 18.3 to 103.5) for esophageal adenocarcinoma and 4.4 (95% CI, 1.7 to 11.0) for cardia adenocarcinoma. Reflux symptoms were not associated with esophageal squamous-cell carcinoma (OR 1.1, 95% CI, 0.7 to 1.9).
Shows an association, not proof of cause and effect.
- Study type
- Population-based case-control study
- Who was studied
- 189 esophageal adenocarcinoma, 262 cardia adenocarcinoma, and 167 esophageal squamous-cell carcinoma patients, plus 820 control subjects in Sweden
- What was measured
- Risk of esophageal adenocarcinoma, adenocarcinoma of the gastric cardia, and esophageal squamous-cell carcinoma
THE PAPER
Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.
Lagergren J, Bergström R, Lindgren A, Nyrén O. N Engl J Med, 1999.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.